Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | THRA | P10827 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9421500 | 0.89 | KMT2A (0.36) | KMT2ATHRATHRBHSD17B10TDP1 | |
| Acetic Acid SCHEMBL585034 | 0.89 | KMT2A (0.36) | KMT2ATHRATHRBALDH1A1TSHR | |
| SCHEMBL295509 | 0.89 | KMT2A (0.41) | KMT2ATHRATHRBTDP1 | |
| SCHEMBL5528 | 0.89 | — | — | |
| Hydrochloric Acid SCHEMBL10608471 | 0.87 | — | — | |
| Water SCHEMBL9815377 | 0.87 | — | — | |
| Charcoal, Activated SCHEMBL8216968 | 0.87 | — | — | |
| Formaldehyde SCHEMBL9633220 | 0.87 | KMT2A (0.40) | KMT2ATHRATHRBTDP1 | |
| SCHEMBL3170410 | 0.85 | KMT2A (0.39) | KMT2ATHRATHRBTDP1 | |
| Methacrylic Acid SCHEMBL1248311 | 0.84 | KMT2A (0.33) | KMT2ATHRATHRBTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107097502-A | Stick pack easily tears composite membrane and its manufacture method | 浙江金石包装有限公司 | 2017-08-29 | — | — | CN | claimed |
| CN-106413695-B | Rivastigmine transdermal compositions and methods of use thereof | 帝国制药美国公司 | 2019-12-10 | — | — | CN | disclosed |
| CN-107768449-B | Solar cell module | LG电子株式会社 | 2019-11-05 | — | — | CN | disclosed |
| US-10357463-B2 | Rivastigmine transdermal compositions and methods of using the same | TEIKOKU PHARMA USA, INC. (US) | 2019-07-23 | — | — | US | disclosed |
| CN-108641621-A | A kind of metal surface pre-coating film and preparation method thereof | 重庆新康意安得达尔新材料有限公司 | 2018-10-12 | — | — | CN | disclosed |
| US-20180193285-A1 | Rivastigmine Transdermal Compositions and Methods of Using the Same | TEIKOKU PHARMA USA, INC. | 2018-07-12 | — | — | US | disclosed |
| CN-108047826-A | A kind of organosilicon polymer complex emulsions and preparation method thereof | 南通福伦利新材料有限公司 | 2018-05-18 | — | — | CN | disclosed |
| US-9949935-B2 | Rivastigmine transdermal compositions and methods of using the same | TEIKOKU PHARMA USA, INC. (US) | 2018-04-24 | — | — | US | disclosed |
| CN-107768449-A | Solar module | LG电子株式会社 | 2018-03-06 | — | — | CN | disclosed |
| CN-105226120-B | solar cell module | LG电子株式会社 | 2017-12-01 | — | — | CN | disclosed |
| WO-2011003107-A2 | A SEALABLE MATERIAL AND METHOD OF FORMING A DIELECTRIC WELD | SAINT-GOBAIN PERFORMANCE PLASTICS CORPORATION (US) | 2011-01-06 | — | — | WO | disclosed |
| US-20110003104-A1 | SEALABLE MATERIAL AND METHOD OF FORMING A DIELECTRIC WELD | SAINT-GOBAIN PERFORMANCE PLASTICS CORPORATION (US) | 2011-01-06 | — | — | US | disclosed |
| EP-0938600-B1 | Dental floss | PERI DENT LTD (GB) | 2006-12-06 | — | — | EP | disclosed |
| US-6303063-B1 | Process of making a yarn | PERI-DENT LIMITED (GB) | 2001-10-16 | — | — | US | disclosed |
| EP-0938600-A1 | PLASTICS MATERIALS YARN | Peri-Dent Limited (GB) | 1999-09-01 | — | — | EP | disclosed |
| WO-1998050607-A1 | PLASTICS MATERIALS YARN | PERI-DENT LIMITED (GB) | 1998-11-12 | — | — | WO | disclosed |
| EP-0408296-A1 | Comfortable ostomy pouch | W.R. Grace & Co.-Conn. (US) | 1991-01-16 | — | — | EP | disclosed |
| US-4915963-A | MULTILAYER FILM USING ETHYLENE VINYL ACETATE AS INNER LAYER; SEALING, STUFFING | VISKASE CORPORATION (US) | 1990-04-10 | — | — | US | disclosed |
| US-4784863-A | BARRIER LAYER AS CORE, ADHESION TO MEAT | VISKASE CORPORATION (US) | 1988-11-15 | — | — | US | disclosed |
| US-4749084-A | Tamper-indicating package with randomly disposed filaments | MINNESOTA MINING AND MANUFACTURING CO. (US) | 1988-06-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10357463-B2 | Rivastigmine transdermal compositions and methods of using the same | ACHE, CHRNE, CHRNA7 | KMT2A 722/4885THRA 1823/4885THRB 2610/4885 |
| US-20180193285-A1 | Rivastigmine Transdermal Compositions and Methods of Using the Same | ACHE, CHRNE, CHRNA7 | KMT2A 722/4885THRA 1823/4885THRB 2610/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.